Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI
NCT06275035
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
101
Enrollment
OTHER
Sponsor class
Conditions
Neurocognitive Dysfunction
Interventions
DRUG:
Memantine Oral Tablet
Sponsor
Tata Memorial Centre